Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathology induced by interleukin-6.

B Ryffel1, M Kammüller, R Robison

  • 1University of Zurich, Institute of Toxicology, Schwerzenbach-Zurich, Switzerland.

Toxicology Letters
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Restaurants as Environments for Healthy Eating: Factors That Contribute to Restaurant-Based Healthy Eating Program Adoption.

Health promotion practice·2024
Same author

Accurately evaluating for a small bowel obstruction using an abdominal radiograph, by a new method: The Bowel-Spine Ratio.

Radiography (London, England : 1995)·2023
Same author

Evaluating changes to home bowel cancer screening kits: an end-user perspective study.

Cancer causes & control : CCC·2023
Same author

Scoping health literacy in Latin America.

Global health promotion·2021
Same author

7X multiplexed, optofluidic detection of nucleic acids for antibiotic-resistance bacterial screening.

Optics express·2020
Same author

Good emergency management practices: a review of the core principles, with a focus on preparedness.

Revue scientifique et technique (International Office of Epizootics)·2020
Same journal

Size- and morphology-dependent cytotoxicity of metal-organic frameworks: Deciphering the structure-toxicity relationship.

Toxicology letters·2026
Same journal

Steroidogenesis suppression in H295R cells by 1,3-disubstituted ureas: A potential off-target effect of some sEH inhibitors.

Toxicology letters·2026
Same journal

Signaling pathways in tobacco smoking-induced cervical carcinogenesis: Beyond HPV-mediated activation.

Toxicology letters·2026
Same journal

Neurobehavioral, cholinergic and histopathological alterations induced by copper oxide nanoparticles in male mice.

Toxicology letters·2026
Same journal

Toxicology and biodistribution of plant-derived extracellular vesicles for drug delivery: Quality control, safety mechanisms, and translational testing priorities.

Toxicology letters·2026
Same journal

Effects of combustible cigarettes and heated tobacco products on immunomodulatory and hepatoprotective properties of mesenchymal stem cells in acute liver failure.

Toxicology letters·2026
See all related articles

High doses of recombinant human interleukin-6 (rhIL-6) stimulated immune and blood cell production in mice, rats, and primates. No significant organ damage was observed, though neutralizing antibodies formed.

Area of Science:

  • Immunology and Hematology
  • Cytokine Research
  • Preclinical Toxicology

Background:

  • Interleukin 6 (IL-6) is a key cytokine involved in immune responses, hematopoiesis, and host defense.
  • Understanding the effects of therapeutic IL-6 administration is crucial for its clinical application.

Purpose of the Study:

  • To evaluate the biological effects and safety profile of high-dose recombinant human IL-6 (rhIL-6) in preclinical animal models.
  • To assess the immunomodulatory, hematopoietic, and toxicological impacts of rhIL-6 administration across species.

Main Methods:

  • Administration of high-dose rhIL-6 to mice, rats, and non-human primates.
  • Monitoring of immune response, hematopoietic parameters (particularly megakaryocytes), and acute phase reactions.
  • Histopathological examination of major organs, including the liver and kidneys, for signs of toxicity.

Related Experiment Videos

  • Detection of neutralizing antibodies against rhIL-6.

    • Main Results:

    • rhIL-6 demonstrated immunostimulatory and hematopoietic effects, notably enhancing megakaryopoiesis, in all tested species.
    • A pronounced acute phase response was observed in non-human primates without significant liver histopathological changes.
    • No evidence of glomerular pathology was detected in any species.
    • Neutralizing antibodies against rhIL-6 were present within 10 days post-administration in all animal models.

    Conclusions:

    • High-dose rhIL-6 exhibits significant immunostimulatory and hematopoietic effects in preclinical models.
    • The administration of rhIL-6 appears to be well-tolerated with no major organ toxicity observed.
    • The induction of neutralizing antibodies suggests potential limitations for sustained rhIL-6 therapy.